Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 5Phase 3 3Phase 1 3Phase 1/2 2Phase NA 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Dermatologic 1

Conditions

Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Early Stage Non-Small Cell Lung Cancer 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Vancomycin × Clear all
NCT07478848 2026-05-22

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Abramson Cancer Center at Penn Medicine

Phase 1 Not yet recruiting
14 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03546829 2026-01-14

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Abramson Cancer Center at Penn Medicine

Phase 1 Recruiting
10 enrolled
Thoracic

Early Stage Non-Small Cell Lung Cancer

NCT06540391 2025-09-26

MELODY-1

Microbiotica Ltd

Phase 1 Active not recruiting
41 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡